Brookfield Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-26,305
| Closed | -$7.49M | – | 163 |
|
2023
Q2 | $7.49M | Sell |
26,305
-7,022
| -21% | -$2M | 0.03% | 195 |
|
2023
Q1 | $9.27M | Buy |
33,327
+11,947
| +56% | +$3.32M | 0.04% | 178 |
|
2022
Q4 | $5.92M | Sell |
21,380
-5,066
| -19% | -$1.4M | 0.02% | 224 |
|
2022
Q3 | $7.06M | Buy |
+26,446
| New | +$7.06M | 0.03% | 221 |
|
2022
Q2 | – | Sell |
-14,763
| Closed | -$3.11M | – | 589 |
|
2022
Q1 | $3.11M | Buy |
14,763
+10,763
| +269% | +$2.27M | 0.01% | 324 |
|
2021
Q4 | $960K | Buy |
4,000
+1,290
| +48% | +$310K | ﹤0.01% | 443 |
|
2021
Q3 | $767K | Buy |
2,710
+825
| +44% | +$233K | ﹤0.01% | 439 |
|
2021
Q2 | $653K | Buy |
+1,885
| New | +$653K | ﹤0.01% | 481 |
|